Frank Behrens is Director of the Center of Innovative Diagnostics and Therapeutics Rheumatology/Immunology (CIRI), Head of Clinical Research in the Fraunhofer-Institute IME, Translational Medicine and Pharmacology at the Goethe University of Frankfurt, and a member of the board of directors of the Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (IMD), all in Frankfurt am Main, Germany. He earned a degree in medicine after studying biology at Mainz University (Mainz, Germany), and later received his doctorate of medicine. He went on to train in internal medicine and rheumatology at the Hospital of Friedrichsheim Foundation and the Frankfurt University Medical Center, and conducted grant-funded research on regulatory T cells in rheumatic diseases at the Institute of Immune Pharmacology in Frankfurt. Dr Behrens is also Associated Professor of internal medicine and rheumatology at Goethe University.
Dr Behrens’ major research interests include the pathogenesis of synovitis and angiogenesis in inflammatory diseases, and the development and evaluation of innovative therapeutic concepts in psoriatic arthritis, rheumatoid arthritis, and systemic sclerosis. Since 2001, he has accumulated experience in clinical trials as Principal Investigator, Chief Investigator, and Managing Investigator. He is responsible for several investigator-initiated studies in rheumatic diseases.
Dr Behrens has published numerous peer-reviewed articles and is (co-)author of several textbooks in the area of rheumatic diseases. He is a member of various international committees and study groups, such as the Group of Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Expert Panel on Outcome of Systemic Sclerosis (EPOSS), and the Psoriatic Arthritis Genetic European Consortium (PAGE).
EM-38391 - Date of preparation: October 2020